Investors in DiaSorin S.p.A. (BIT:DIA) had a good week, as its shares rose 5.1% to close at €110 following the release of its yearly results. It was an okay result overall, with revenues coming in at ...

DiaSorin (BIT:DIA) shares have had a really impressive month, gaining 42%, after some slippage. Looking back a bit further, we're also happy to report the stock is up 73% in the last year. Assuming no ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Italian medical diagnostic group Diasorin on Friday reported a double-digit drop in revenue for 2023, in line with its ...

DiaSorin SpA (MILAN:DIAS) projected revenue growth of 5% to 6% for 2026 and a compound annual growth rate of 6% to 8% from 2026 through 2030. The company forecast ...

The LIAISON® LymeDetect® assay is a solution for the early diagnosis of Lyme Borreliosis combining detection of IgG and IgM Antibodies and cellular immunity The test is available in countries ...

HILDEN, Germany & SALUGGIA, Italy--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced that the U.S. Food and Drug Administration (FDA) has ...

Shares in DiaSorin jumped as much as 10% on Monday after the Italian diagnostics group said it was buying U.S. rival Luminex Corp in a $1.8 billion all-cash deal that strengthens its molecular ...

MeMed partners with Italy’s DiaSorin to commercialize bacteria vs virus test Test to be integrated in over 5,000 DiaSorin analyzers, allowing physicians to differentiate between bacterial and viral ...

DiaSorin will buy Quest Diagnostics’ Focus Diagnostics immunodiagnostic and molecular diagnostic products business for $300 million cash, the companies said today. The deal is designed to expand ...

The U.S Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response has awarded $2.6 million to DiaSorin – an Italy-based biotechnology company with ...

An icon in the shape of a lightning bolt. Impact Link A billionaire-led Italian pharmaceutical company has developed a faster way to test for the novel coronavirus that is sweeping the globe — and ...